PFE Pfizer Inc

Price (delayed)

$52.31

Market cap

$293.51B

P/E Ratio

11.78

Dividend/share

$1.58

EPS

$4.44

Enterprise value

$327.34B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
Pfizer's net income has surged by 134% YoY and by 14% QoQ
Pfizer's EPS has soared by 132% YoY and by 13% from the previous quarter
The quick ratio has grown by 8% YoY but it has contracted by 5% from the previous quarter
The gross margin has contracted by 21% YoY and by 2.7% from the previous quarter

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.61B
Market cap
$293.51B
Enterprise value
$327.34B
Valuations
Price to earnings (P/E)
11.78
Price to book (P/B)
3.57
Price to sales (P/S)
3.18
EV/EBIT
12.04
EV/EBITDA
10.12
EV/Sales
3.54
Earnings
Revenue
$92.37B
EBIT
$27.19B
EBITDA
$32.34B
Free cash flow
$31.78B
Per share
EPS
$4.44
Free cash flow per share
$5.66
Book value per share
$14.66
Revenue per share
$16.44
TBVPS
$18.48
Balance sheet
Total assets
$183.84B
Total liabilities
$101.16B
Debt
$36.3B
Equity
$82.42B
Working capital
$15.15B
Liquidity
Debt to equity
0.44
Current ratio
1.39
Quick ratio
0.95
Net debt/EBITDA
1.05
Margins
EBITDA margin
35%
Gross margin
60.4%
Net margin
27%
Operating margin
30%
Efficiency
Return on assets
14%
Return on equity
32.7%
Return on invested capital
27.7%
Return on capital employed
18.8%
Return on sales
29.4%
Dividend
Dividend yield
3.02%
DPS
$1.58
Payout ratio
35.6%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
-0.23%
1 week
1.4%
1 month
-0.11%
1 year
32.23%
YTD
-11.41%
QTD
-0.23%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$92.37B
Gross profit
$55.77B
Operating income
$27.68B
Net income
$24.97B
Gross margin
60.4%
Net margin
27%
The operating income has soared by 180% YoY and by 14% from the previous quarter
Pfizer's net income has surged by 134% YoY and by 14% QoQ
Pfizer's revenue has surged by 100% YoY and by 14% QoQ
Pfizer's gross profit has soared by 58% YoY and by 11% from the previous quarter

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
P/E
11.78
P/B
3.57
P/S
3.18
EV/EBIT
12.04
EV/EBITDA
10.12
EV/Sales
3.54
Pfizer's EPS has soared by 132% YoY and by 13% from the previous quarter
The price to earnings (P/E) is 27% lower than the 5-year quarterly average of 16.2 and 16% lower than the last 4 quarters average of 14.1
Pfizer's equity has increased by 20% YoY and by 7% QoQ
PFE's P/B is 5% above its 5-year quarterly average of 3.4 and 2% above its last 4 quarters average of 3.5
Pfizer's revenue has surged by 100% YoY and by 14% QoQ
PFE's P/S is 32% below its 5-year quarterly average of 4.7 and 14% below its last 4 quarters average of 3.7

Efficiency

How efficient is Pfizer business performance
The company's return on invested capital has surged by 147% YoY and by 12% QoQ
Pfizer's ROA has soared by 119% YoY and by 9% from the previous quarter
The ROE has soared by 101% YoY and by 8% QoQ
Pfizer's ROS has increased by 18% YoY

Dividends

What is PFE's dividend history
DPS
$1.58
Dividend yield
3.02%
Payout ratio
35.6%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 82% greater than its total liabilities
PFE's total assets is up by 16% year-on-year
The company's total liabilities rose by 12% YoY but it fell by 2.7% QoQ
PFE's debt is 56% less than its equity
The debt to equity has contracted by 24% YoY and by 12% from the previous quarter
Pfizer's equity has increased by 20% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.